[1]
|
李强. 中国2型糖尿病合并血脂异常防治专家共识(2017年修订版) [J]. 中华内分泌代谢杂志, 2017, 33(11): 925-936.
|
[2]
|
Surdu, A.M., Pînzariu, O., Ciobanu, D.M., et al. (2021) Vitamin D and Its Role in the Lipid Metabolism and the Development of Atherosclerosis. Biomedicines, 9, Article No. 172. https://doi.org/10.3390/biomedicines9020172
|
[3]
|
Cheng, H.S., Tan, W.R., Low, Z.S., et al. (2019) Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence. International Journal of Molecular Sciences, 20, Article No. 5055.
https://doi.org/10.3390/ijms20205055
|
[4]
|
Ning, C., Liu, L., Lv, G., et al. (2015) Lipid Metabolism and Inflamma-tion Modulated by Vitamin D in Liver of Diabetic rats. Lipids in Health and Disease, 14, Article No. 31. https://doi.org/10.1186/s12944-015-0030-5
|
[5]
|
Yoneda, M., Honda, Y., Ogawa, Y., et al. (2021) Comparing the Effects of Tofogliflozin and Pioglitazone in Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus (ToPiND Study): A Randomized Prospective Open-Label Controlled Trial. BMJ Open Diabetes Research and Care, 9, e001990.
https://doi.org/10.1136/bmjdrc-2020-001990
|
[6]
|
Li, J., Mihalcioiu, M., Li, L., et al. (2018) Vitamin D Prevents Lipid Accumulation in Murine Muscle through Regulation of PPARγ and Perilipin-2 Expression. The Journal of Steroid Biochemistry and Molecular Biology, 177, 116-124.
https://doi.org/10.1016/j.jsbmb.2017.10.010
|
[7]
|
Hoseini, R., Damirchi, A. and Babaei, P. (2017) Vitamin D In-creases PPARγ Expression and Promotes Beneficial Effects of Physical Activity in Metabolic Syndrome. Nutrition, 36, 54-59. https://doi.org/10.1016/j.nut.2016.06.010
|
[8]
|
Christofides, A., Konstantinidou, E., Jani, C., et al. (2021) The Role of Peroxisome Proliferator-Activated Receptors (PPAR) in Immune Responses. Metabolism, 114, Article ID: 154338. https://doi.org/10.1016/j.metabol.2020.154338
|
[9]
|
Khodir, S.A., Samaka, R.M. and Ameen, O. (2020) Autophagy and mTOR Pathways Mediate the Potential Renoprotective Effects of Vitamin D on Diabetic Nephropathy. International Journal of Nephrology, 2020, Article ID: 7941861. https://doi.org/10.1155/2020/7941861
|
[10]
|
Li, R., Guo, E., Yang, J., et al. (2017) 1,25(OH)2D3 Attenuates Hepatic Steatosis by Inducing Autophagy in Mice. Obesity, 25, 561-571. https://doi.org/10.1002/oby.21757
|
[11]
|
Lee, H., Lee, H. and Lim, Y. (2020) Vitamin D3 Improves Lipophagy-Associated Renal Lipid Metabolism and Tissue Damage in Diabetic Mice. Nutrition Research, 80, 55-65. https://doi.org/10.1016/j.nutres.2020.06.007
|
[12]
|
Asano, L., Watanabe, M., Ryoden, Y., et al. (2017) Vitamin D Metabolite, 25-Hydroxyvitamin D, Regulates Lipid Metabolism by Inducing Degradation of SREBP/SCAP. Cell Chem-ical Biology, 24, 207-217.
https://doi.org/10.1016/j.chembiol.2016.12.017
|
[13]
|
Xiaoxin, X.W., Tao, J., Yan, S., et al. (2011) Vitamin D Re-ceptor agonist Doxercalciferol Modulates Dietary Fat-Induced Renal Disease and Renal Lipid Metabolism. American Journal of Physiology—Renal Physiology, 300, F801-F810. https://doi.org/10.1152/ajprenal.00338.2010
|
[14]
|
Tian, L.Q., Shi, W.Q., Zhou, Y., et al. (2019) The Association of Serum Vitamin D Deficiency and Metabolic Risk Factors in Chinese Adults with Prediabetes: A Cross-Sectional Study. Journal of Nutritional Science and Vitaminology, 65, 211-218. https://doi.org/10.3177/jnsv.65.211
|
[15]
|
Zhang, M., Yu, F., Xue, Y., et al. (2022) The Relationship of 25(OH)D3 with Diabetes Mellitus and the Mediation Effect of Lipid Profile in Chinese Rural Population of Henan Prov-ince. Medicina, 58, Article No. 85.
https://doi.org/10.3390/medicina58010085
|
[16]
|
龚彤, 韩雪, 胡欣, 等. 不同体重的住院2型糖尿病患者血清维生素D水平与血脂之间的关系[J]. 中华内分泌代谢杂志, 2020, 36(12): 1032-1038.
|
[17]
|
张雯欣, 范颂, 刘霞, 等. 不同体质指数和血脂水平老年人糖尿病患病情况的纵向数据研究[J]. 中国全科医学, 2022, 25(9): 1093-1097.
|
[18]
|
Wenclewska, S., Szymczak-Pajor, I., Drzewoski, J., et al. (2019) Vitamin D Supplementation Reduces Both Oxidative DNA Damage and Insulin Resistance in the Elderly with Metabolic Disorders. International Journal of Molecular Sciences, 20, Article No. 2891. https://doi.org/10.3390/ijms20122891
|
[19]
|
Moreira-Lucas, T.S., Duncan, A.M., Rabasa-Lhoret, R., et al. (2017) Effect of Vitamin D Supplementation on Oral Glucose Tolerance in Individuals with Low Vitamin D Status and Increased Risk for Developing Type 2 Diabetes (EVIDENCE): A Double-Blind, Ran-domized, Placebo-Controlled Clinical Trial. Diabetes, Obesity and Metabolism, 19, 133-141. https://doi.org/10.1111/dom.12794
|
[20]
|
Angellotti, E., D’Alessio, D., Dawson-Hughes, B., et al. (2019) Effect of Vitamin D Supplementation on Cardiovascular Risk in Type 2 Diabetes. Clinical Nutrition, 38, 2449-2453. https://doi.org/10.1016/j.clnu.2018.10.003
|
[21]
|
Alves, A.G.P., Cruvinel, B.A.C., Schincaglia, R.M., et al. (2021) Vitamin D Supplementation Reduces Serum Lipids of Children with Hypertriacylglycerolemia: A Randomized, Tri-ple-Masked, Placebo-Controlled Crossover Trial. Nutrition, 89, Article ID: 111296. https://doi.org/10.1016/j.nut.2021.111296
|
[22]
|
Kim, J., Nam, J.S., Kim, H., et al. (2021) No Effect of Vitamin D Supplementation on Metabolic Parameters but on Lipids in Patients with Type 2 Diabetes and Chronic Kidney Disease. International Journal for Vitamin and Nutrition Research, 91, 649-658. https://doi.org/10.1024/0300-9831/a000642
|
[23]
|
Barzegari, M., Sarbakhsh, P., Mobasseri, M., et al. (2019) The Effects of Vitamin D Supplementation on Lipid Profiles and Oxidative Indices among Diabetic Nephropathy Patients with Marginal Vitamin D Status. Diabetes & Metabolic Syndrome, 13, 542-547. https://doi.org/10.1016/j.dsx.2018.11.008
|